Ying Guo

Ying Guo

Auto-generated profile, based on publicly available information

Ying Guo

Department of Cell Systems & Anatomy, University of Texas Health San Antonio, San Antonio, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2021 in Science Advances
Verified
Journal Article
Open access
PZPeng Zhang
Peng Zhang
PSPinpin Sui
Pinpin Sui
SCShi Chen
Shi Chen
YGYing Guo
Ying Guo
YLYing Li
Ying Li
FYFeng-Chun Yang
Feng-Chun Yang
INTS11, the catalytic subunit of the Integrator complex, regulates hematopoietic stem cell function through PRC2 proteins.

2 January 2024 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
GGGuo Ge
Guo Ge
PZPeng Zhang
Peng Zhang
PSPinpin Sui
Pinpin Sui
SCShi Chen
Shi Chen
HYHui Yang
Hui Yang
FYFeng-Chun Yang
Feng-Chun Yang
ASXL1 mutation frequently occurs in all forms of myeloid malignancies and is associated with aggressive disease and poor prognosis. ASXL1 recruits Polycomb repressive complex 2 (PRC2) to specific gene loci to repress transcription through trimethylation of histone H3 on lysine 27 (H3K27me3). ASXL1 alterations reduce H3K27me3 levels, which results in leukemogenic gene expression and the development of myeloid malignancies. Standard therapies for myeloid malignancies have limited efficacy when mutated ASXL1 is present. We discovered upregulation of lysine demethylase 6B (KDM6B), a demethylase for H3K27me3, in ASXL1-mutant leukemic cells, which further reduces H3K27me3 levels and facilitates myeloid transformation. Here, we demonstrated that heterozygous deletion of Kdm6b restored H3K27me3 levels and normalized dysregulated gene expression in Asxl1Y588XTg hematopoietic stem/progenitor cells (HSPCs). Furthermore, heterozygous deletion of Kdm6b decreased the HSPC pool, restored their self-renewal capacity, prevented biased myeloid differentiation, and abrogated progression to myeloid malignancies in Asxl1Y588XTg mice. Importantly, administration of GSK-J4, a KDM6B inhibitor, not only restored H3K27me3 levels but also reduced the disease burden in NSG mice xenografted with human ASXL1-mutant leukemic cells in vivo. This preclinical finding provides compelling evidence that targeting KDM6B may be a therapeutic strategy for myeloid malignancies with ASXL1 mutations.

25 August 2021 in Mitochondrial DNA Part B
Verified
Journal Article
Open access
YGYing Guo
Ying Guo
HWHafiz Muhammad Wariss
Hafiz Muhammad Wariss
RZRong Zhang
Rong Zhang
Lessertia frutescens (L.) Goldblatt & J. C. Manning 2000 is an endemic species of Southern Africa with high medicinal and economic values. To facilitate exploration of its genetic resource, a complete chloroplast genome was determined using Illumina pair-end sequencing technology. The complete circular genome is 122,700 bp in length with overall 34.2% GC contents. It encodes a total of 110 genes, including 76 protein-coding genes, 30 tRNA, and four rRNA genes. The maximum-likelihood (ML) phylogenetic tree indicated that L. frutescens nested within the Papilionoideae and had a close relationship with Astragalus nakaianus and A. mongholicus. The newly sequenced complete chloroplast genome will help understanding the plastome evolution, genetic diversity and contribute to the genetic conservation of the natural population of L. frutescens.

26 January 2026 in Leukemia
Verified
Journal Article
Closed access
PDF file
YGYing Guo
Ying Guo
PSPinpin Sui
Pinpin Sui
HYHui Yang
Hui Yang
GZGanqian Zhu
Ganqian Zhu
YLYing Li
Ying Li
FYFeng-Chun Yang
Feng-Chun Yang